Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001127602-10-009044
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-03-17 13:00:00
Reporting Period:
2010-03-15
Filing Date:
2010-03-17
Accepted Time:
2010-03-17 19:24:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1073431 Life Technologies Corp LIFE Biological Products, (No Disgnostic Substances) (2836) 330373077
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1251299 T Gregory Lucier 5791 Van Allen Way
Carlsbad CA 92008
Chief Executive Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-15 11,266 $53.13 488,052 No 4 M Direct
Common Stock Disposition 2010-03-15 5,259 $53.13 482,793 No 4 F Direct
Common Stock Disposition 2010-03-16 6,007 $52.99 476,786 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2010-03-15 11,266 $0.00 11,266 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-03-14 2018-03-14 No 4 M Indirect
Footnotes
  1. Vesting of RSU Grant #F080168
  2. Shares held to cover tax liability from vesting of Grant #F080168
  3. Common shares sold pursuant to 10b5-1 Plan